PCI’s Tim Roberts discusses key factors when outsourcing the clinical and commercial supply of biologics, and what makes a strong CDMO partnership.
List view / Grid view
PCI Pharma Services
PCI Pharma Services announces major manufacturing expansion with $100 Million investment in New England, providing global capacity to clients
Capabilities include the latest in sterile lyophilisation and liquid filling technology to support global pharmaceutical supply chain, keeping pace with industry trends.
How to select a CDMO partner for the development and commercial manufacture, packaging and launch of products containing highly potent APIs.